GSDME and neoplasm: Also, lobaplatin can activate caspase-3 in CRC cell lines HT-29 and HCT-116, leading to the cleavage of GSDME and subsequent occurrence of pyroptosis-like features, such as plasma membrane swelling and pore formation in CRC cells and inhibiting tumor growth [53].